Exact Sciences CEO Sees Steady Uptick in Cologuard Orders

Kevin Conroy, Exact Sciences Corp. chairman and chief executive officer, discusses the company's earnings and demand for Cologuard colon-cancer tests with Bloomberg's Julia Chatterley on "Bloomberg Markets." (Source: Bloomberg)

How to Trade Microsoft Ahead of Earnings
12:54 - Kelly & Co. Managing Partner Kevin Kelly discusses a potential deal between Sprint and T-Mobile and his options trade for Microsoft. He speaks with Bloomberg's Julie Hyman on "Bloomberg Markets." (Source: Bloomberg)
  • Full Show: Surveillance (09/18)
  • Full Show: What'd You Miss? (09/15)
  • Full Show: Bloomberg Daybreak: Americas (09/15)